FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

WHITE ROBERT JOHN
2. Issuer Name and Ticker or Trading Symbol

Medtronic plc [ MDT ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP & President MITG
(Last)          (First)          (Middle)

MEDTRONIC PLC, 710 MEDTRONIC PKWY MS LC300
3. Date of Earliest Transaction (MM/DD/YYYY)

11/1/2019
(Street)

MINNEAPOLIS, MN 55432
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares  11/1/2019    M(1)    9643  A $29.52  61711 (2) D   
Ordinary Shares  11/1/2019    S(1)    3762  D $109.659 (3) 57949  D   
Ordinary Shares  11/1/2019    M(1)    37209  A $36.58  95158  D   
Ordinary Shares  11/1/2019    S(1)    28428  D $109.108 (4) 66730  D   
Ordinary Shares  11/1/2019    S(1)    14662  D $109.667 (5) 52068  D   
Ordinary Shares  11/1/2019    M(1)    5313  A $47.00  57381  D   
Ordinary Shares  11/1/2019    S(1)    3349  D $109.113 (6) 54032  D   
Ordinary Shares  11/1/2019    S(1)    1964  D $109.663 (7) 52068  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)  $29.52  11/1/2019    M (1)       9643   12/1/2012  11/30/2021  Ordinary Shares  9643  $0  0  D   
Stock Option (Right to Buy)  $36.58  11/1/2019    M (1)       37209   12/3/2013  12/2/2022  Ordinary Shares  37209  $0  0  D   
Stock Option (Right to Buy)  $47.00  11/1/2019    M (1)       5313   12/2/2014  12/1/2023  Ordinary Shares  5313  $0  25442  D   

Explanation of Responses:
(1)  The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
(2)  This balance increased by 151 shares due to exempt transactions such as dividend reinvestment.
(3)  The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.46 to $109.98, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(4)  The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.44 to $109.44, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(5)  The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.45 to $110.18, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(6)  The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.46 to $109.43, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(7)  The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.46 to $110.01, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
WHITE ROBERT JOHN
MEDTRONIC PLC
710 MEDTRONIC PKWY MS LC300
MINNEAPOLIS, MN 55432


EVP & President MITG

Signatures
/s/ Perry F. Sekus, attorney-in-fact 11/4/2019
**Signature of Reporting Person Date


Medtronic (NYSE:MDT)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Medtronic Charts.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Medtronic Charts.
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....